|LETTER TO THE EDITOR
|Year : 2013 | Volume
| Issue : 2 | Page : 245-247
Six novel mutations of ATP2C1 identified in eight Chinese patients with Hailey-Hailey disease
Hongqing Tian1, Mingfei Chen2, Jiabao You2, Xi'an Fu2, Hong Liu2, Zhongxiang Shi3, Meiling Yu3, Mei Wu3, Yongxiang Yu2, Gongqi Yu2, Furen Zhang4
1 Shandong Clinical College of Skin Diseases, Anhui Medical University; Shandong Provincial Hospital for Skin Diseases; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China
2 Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China
3 Shandong Provincial Hospital for Skin Diseases; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China
4 Shandong Clinical College of Skin Diseases, Anhui Medical University; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences; Shandong Provincial Hospital for Skin Diseases; Shandong Provincial Key Lab for Dermatovenereology; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China
|Date of Web Publication||22-Feb-2013|
Shandong Provincial Institute of Dermatology and Venereology, 27397 Jingshi Road, Jinan, Shandong Province, 250022
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Tian H, Chen M, You J, Fu X, Liu H, Shi Z, Yu M, Wu M, Yu Y, Yu G, Zhang F. Six novel mutations of ATP2C1 identified in eight Chinese patients with Hailey-Hailey disease. Indian J Dermatol Venereol Leprol 2013;79:245-7
|How to cite this URL:|
Tian H, Chen M, You J, Fu X, Liu H, Shi Z, Yu M, Wu M, Yu Y, Yu G, Zhang F. Six novel mutations of ATP2C1 identified in eight Chinese patients with Hailey-Hailey disease. Indian J Dermatol Venereol Leprol [serial online] 2013 [cited 2019 Dec 6];79:245-7. Available from: http://www.ijdvl.com/text.asp?2013/79/2/245/107651
Hailey-Hailey disease More Details (HHD; MIM 169600), also known as familial benign chronic pemphigus, is a rare autosomal dominant dermatosis. The disease is characterized by recurrent blisters, crusted erosions, and warty papules occurring mainly in the sites of friction and flexures, particularly the groin [Figure 1], neck, and axillary, perianal, and submammary regions. Histology reveals acantholysis of the epidermis, giving the appearance of a "dilapidated brick wall" [Figure 1]. The ATP2C1 gene on 3q22.1 was identified as the defective gene of HHD. The gene encodes an Adenosine Triphosphate (ATP) powered calcium channel pump, , also known as human secretory pathway Ca 2+ /Mn 2+ ATPase protein 1 (hSPCA1), localized in the Golgi apparatus.  In this paper, we performed mutation analysis of the ATP2C1 gene in four familial HHD patients and four sporadic HHD patients. The patients were diagnosed on clinical and histopathological findings [Figure 1].
|Figure 1: (a) Clinical features of familial case 4 Hailey-Hailey disease (FHHD-4), erythematous and erosive plaques in the genitals, (b) histological features of FHHD-4, the loss of cohesion between the keratinocytes (acantholysis) with a "dilapidated brick wall" appearance (H and E, ×10); (c-j) The sequences shown the mutations of ATP2C1 in FHHD-1, sporadic case 2 Hailey-Hailey disease (SHHD-2), FHHD-3, FHHD-4, SHHD-5, SHHD-6, FHHD-7, and SHHD-8|
Click here to view
After written informed consent and obtaining approval of the ethics committee of the institute, genomic DNA was extracted from the peripheral blood of eight patients (four men, four women; mean ± SD age: 41 ± 9 years, range: 25) and 100 unrelated controls. Exons including exon-intron boundaries of the ATP2C1 gene were amplified by polymerase chain reaction using previous published primers.  After amplification, products were purified and directly sequenced on ABI 3130xl genetic analyzer (Applied Biosystems ABI, Carlsbad, CA, USA).
Seven mutations were identified in our eight HHD patients; six of these were novel [Table 1] and [Figure 1].
In familial case 1 (FHHD-1), sporadic case 2 (SHHD- 2), and FHHD-3, three splicing-site mutations (c.2629 + 5A > G in intron 23, c.2561-17C > T in intron 22, and C.621- 1A > G in intron 2) were conformed [Figure 1], [Table 1], which may affect mRNA splicing though alteration of the invariant splice donor site consensus sequence. The heterozygous mutation A > G at nucleotide 683 in exon 3 was identified in FHHD-4 [Figure 1], [Table 1], resulted in a nonsense mutation P.W60X. One missense mutation c.666T > C (P.R66G) in exon 3 was detected in SHHD- 5 [Figure 1], [Table 1]. And another mutation c.2971A > C (P.A823E) in exon 25 was found in both FHHD-7 and SHHD-8 [Figure 1], [Table 1]. The two missense mutations may affect the transport function for Ca 2+ , and should be useful for further studies on the effect of the mutations on ATP2C1 gene expression. In SHHD-6, a previously reported frameshift mutant c.1523delAT in exon 17 was conformed [Figure 1], [Table 1],  which generated pre-terminating codons at 9 and 23 codons downstream of the deletion site. None of these mutations were found in 100 control individuals.
The ATP-powered calcium channel pump of the human keratinocyte localizes on the Golgi apparatus and competitively transports Ca 2+ and Mn 2+ into it. So, it has an irreplaceable role in controlling the Golgi Ca 2+ stores. To date, more than 110 mutations of ATP2C1 gene have been reported.  In this paper, we reported three splicing-site mutations (c.2629 + 5A > G, c.2561-17C > T, and C.621-1A >) in FHHD-1, SHHD-2, and FHHD-3, respectively and one missense mutations c.666T > C in SHHD-5. An APT2C1 gene with these mutations may encode abnormal gene products. Two mutations, c.683 A > G in FHHD-4 and c.1523delAT in SHHD-6, resulting in premature termination and frameshift may cause a significant and an absence in the level of hSPCA1.
In summary, we report six novel mutations of the ATP2C1 gene and one reported mutation of the ATP2C1 gene in eight Chinese patients, which will further expand the database of ATP2C1 mutations in HHD. We failed to find any relationship between genotype and phenotype, just like the previous reports.
| Acknowledgments|| |
This work was supported by Natural Science Foundation of Shandong Province, China (Y2006C95) and Project of Taishan scholar (2008-) and Project of Medical leading scholar of Shandong Province (2010-).
| References|| |
|1.||Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet 2000;24:61-5. |
|2.||Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J, et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet 2000;9:1131- 40. |
|3.||Behne MJ, Tu CL, Aronchik I, Epstein E, Bench G, Bikle DD, et al. Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores. J Invest Dermatol 2003;121:688-94. |
|4.||Zhang F, Yan X, Jiang D, Tian H, Wang C, Yu L. Eight novel mutations of ATP2C1 identified in 17 Chinese families with Hailey-Hailey disease. Dermatology 2007;215:277-83. |
|5.||Tian H, Yan X, Liu H, Yu Y, Zhang F. Six novel ATP2C1 mutations identified in Chinese patients with Hailey-Hailey disease. J Dermatol Sci 2010;58:80-2. |